Las Vegas Sands Corp (LVS)
Official siteCONSUMER CYCLICAL • RESORTS & CASINOS • NYSE
Market Cap: $25.32B
Last updated: Nov 17, 2026 at 11:06 AM ET
Las Vegas Sands Corp (LVS) Stock Forecast
Analysts expect Las Vegas Sands (LVS) to earn $2.81 per share in the fiscal year ending Dec 31, 2026, on revenue of $13.47B. Of 21 analysts, 14 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 13 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.19, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 14.3% |
| Buy | 11 | 52.4% |
| Hold | 7 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 21
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 10.0% and revenue estimates rise 3.8%.
- Fiscal year ending Dec 31, 2026
- $2.81
- EPS consensus, revenue $13.47B
- Fiscal year ending Dec 31, 2027
- $3.09
- EPS consensus, revenue $13.98B
- Next report
- Jan 26, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.81 | $2.64 to $3.15 | 15 | $13.47B | $13.14B to $13.59B | 18 |
| Dec 31, 2027 | $3.09 | $2.66 to $3.69 | 15 | $13.98B | $12.99B to $14.63B | 18 |
Quarterly Estimates
The EPS consensus rises from $0.74 for the quarter ending Dec 31, 2026 to $0.76 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.74 | $0.60 to $1.01 | 17 | $3.57B | $3.28B to $3.88B | 17 |
| Mar 31, 2027 | $0.76 | $0.66 to $0.86 | 5 | $3.53B | $3.39B to $3.63B | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 18 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 13 |
| Quarter ending Mar 31, 2027 | 0 | 5 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 9.1% from $3.09.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.81 | $2.81 | $3.07 | $3.09 | $3.09 | -8.8% |
| Fiscal year ending Dec 31, 2027 | $3.09 | $3.09 | $3.48 | $3.50 | $3.52 | -12.0% |
| Quarter ending Mar 31, 2027 | $0.76 | $0.76 | $0.93 | $0.94 | $0.94 | -19.0% |
Frequently Asked Questions About LVS
What is the LVS stock forecast?
Consensus analyst estimates put Las Vegas Sands's EPS at $2.81 for the fiscal year ending Dec 31, 2026, on revenue of $13.47B. The consensus rating from 21 analysts is Buy.
How do analysts rate LVS stock?
Of 21 analysts covering Las Vegas Sands, 3 rate it Strong Buy, 11 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from LVS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.81, with estimates from $2.64 to $3.15 from 15 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.09, with estimates from $2.66 to $3.69 from 15 analysts.
What revenue do analysts expect from Las Vegas Sands next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $13.47B, with estimates from $13.14B to $13.59B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $13.98B, with estimates from $12.99B to $14.63B.
How many analysts cover LVS?
21 analysts rate Las Vegas Sands stock, and 15 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
LVS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors